CD8A and neoplasm: Indomethacin (IND), a nonsteroidal anti-inflammatory drug, reduces tumor-induced MDSC accumulation, increases CD8+ T-cell infiltration, reduces Treg infiltration, alleviates chronic inflammation, and inhibits tumor progression and metastasis [144].